To compare efficacy of Rasanjana Ghrita Madhu Anjana in management of Sirotpata

Randomized controlled clinical trial to assess the efficacy of Rasanjana Ghrita Madhu Anjana in the management of Sirotpata with special reference to Episcleritis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107364

Enrollment

Registered

2026-04-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H151- Episcleritis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients willing for trial 2) Patients of age group between 18 to 60 years of both sex. 3) Patients having symptoms of Sirotpata as per Ayurveda (Vedana, Tamravarna siras). 4) Patients of simple and nodular episcleritis.

Exclusion criteria

Exclusion criteria: 1) Patient suffering from infectious diseases such as trachoma, dacryocystitis, conjunctivitis, corneal ulcer, stye. 2) Patient suffering from bleeding disorder like purpura, haemophillia, scurvy. 3) Recently operated eye.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Rasaniana Ghrita Madhu Anian in the management of Sirotpata w.s.r. to EpiscleritisTimepoint: 15 Days	—

Secondary

Measure	Time frame
) To study the classical literature of Sirotpata Vyadhi. 2) Detailed study of Episcleritis. 3) To study Anjana in detailTimepoint: 15 Days	—

Countries

India

Contacts

Public ContactDr Akhilesh Sanjay Vispute

L.K.R. Ayurved Mahavidyalaya Gadhinglaj

dr.poonam2785@gmail.com8605657046

Outcome results